Joseph L Calles

Summary

Affiliation: Michigan State University
Country: USA

Publications

  1. ncbi Psychopharmacology for the violent adolescent
    Joseph L Calles
    Department of Psychiatry, College of Human Medicine, Michigan State University, A236 East Fee Hall, East Lansing, 48824, USA
    Prim Care 33:531-44. 2006
  2. ncbi Depression in children and adolescents
    Joseph L Calles
    College of Human Medicine, Michigan State University, Department of Psychiatry, A236 East Fee Hall, East Lansing, MI 48824, USA
    Prim Care 34:243-58; abstract vi. 2007
  3. ncbi Use of psychotropic medications in children with developmental disabilities
    Joseph L Calles
    Department of Psychiatry, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA
    Pediatr Clin North Am 55:1227-40, ix. 2008
  4. ncbi Psychopharmacologic control of aggression and violence in children and adolescents
    Joseph L Calles
    Department of Psychiatry, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA
    Pediatr Clin North Am 58:73-84, x. 2011
  5. ncbi Cognitive-adaptive disabilities
    Joseph L Calles
    Department of Psychiatry, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA
    Pediatr Clin North Am 58:189-203, xii. 2011
  6. ncbi Genetic and nongenetic factors influencing substance use by adolescents
    Michael R Liepman
    Department of Psychiatry, Michigan State University/Kalamazoo Center for Medical Studies, 49048, USA
    Adolesc Med 13:375-401, viii. 2002

Collaborators

  • Michael R Liepman
  • Suhail Sheikh
  • Leena Kizilbash
  • Ahsan Nazeer

Detail Information

Publications6

  1. ncbi Psychopharmacology for the violent adolescent
    Joseph L Calles
    Department of Psychiatry, College of Human Medicine, Michigan State University, A236 East Fee Hall, East Lansing, 48824, USA
    Prim Care 33:531-44. 2006
    ..Table 1 summarizes several clinical conditions associated with aggressive and violent behaviors, and the recommendations for first-, second-, and third-line pharmacotherapeutic agents to treat them...
  2. ncbi Depression in children and adolescents
    Joseph L Calles
    College of Human Medicine, Michigan State University, Department of Psychiatry, A236 East Fee Hall, East Lansing, MI 48824, USA
    Prim Care 34:243-58; abstract vi. 2007
    ..This article discusses the epidemiology, clinical features, comorbid conditions, risk and protective factors, treatment modalities, and clinical course of early-onset depression...
  3. ncbi Use of psychotropic medications in children with developmental disabilities
    Joseph L Calles
    Department of Psychiatry, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA
    Pediatr Clin North Am 55:1227-40, ix. 2008
    ..This article describes three developmental disorders-autistic spectrum disorders, fragile X syndrome, and fetal alcohol syndrome-and their associated mental health issues, and provides recommendations for pharmacologic interventions...
  4. ncbi Psychopharmacologic control of aggression and violence in children and adolescents
    Joseph L Calles
    Department of Psychiatry, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA
    Pediatr Clin North Am 58:73-84, x. 2011
    ..Tables with recommended agents for each psychiatric disorder, as well as dosing ranges for each agent, are included...
  5. ncbi Cognitive-adaptive disabilities
    Joseph L Calles
    Department of Psychiatry, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA
    Pediatr Clin North Am 58:189-203, xii. 2011
    ..This article reviews the epidemiology, associated psychopathology, and pharmacologic treatment of selected CADs...
  6. ncbi Genetic and nongenetic factors influencing substance use by adolescents
    Michael R Liepman
    Department of Psychiatry, Michigan State University/Kalamazoo Center for Medical Studies, 49048, USA
    Adolesc Med 13:375-401, viii. 2002
    ..More research into the genetic risk factors and applications of current knowledge to treatment is needed...